Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|5|714-724

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.5, 2011-02, pp. : 714-724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2613-2618

Bentham Science Publishers

Access to resources Recommend Favorite

Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches

By  

Current Medicinal Chemistry, Vol. 22, Iss. 24, 2015-01 ,pp. : 2871-2901

Bentham Science Publishers

Access to resources Recommend Favorite

Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 2, 2013-01 ,pp. : 180-200

Bentham Science Publishers

Access to resources Recommend Favorite

Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction

By Tsioufis Costas   Aggelis Athanasios   Dimitriadis Kyriakos   Thomopoulos Costas   Kasiakogias Alexandros   Tzamou Vanessa   Kyvelou Stella-Maria   Mikhailidis Dimitri P.   Papademetriou Vasilios   Stefanadis Christodoulos  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 12, 2011-12 ,pp. : 1347-1353

Informa Healthcare

Access to resources Recommend Favorite

Asymmetric Dimethylarginine: a Novel Cardiovascular Risk Factor in End-stage Renal Disease

By Alsagaff M Yusuf   Thaha M   Aminuddin M   Yogiarto RM   Yogiantoro M   Tomino Y  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 340-349

Field House Publishing

Access to resources Recommend Favorite